Eleni Venetsanakos
- Oncology top 10%
- Immunology and Allergy top 10%
-
- Melanoma and MAPK Pathways 5
- Fibroblast Growth Factor Research 4
- Epigenetics and DNA Methylation 2
- Protein Kinase Regulation and GTPase Signaling 2
-
- Cancer Research and Treatments 3
-
- Cancer Mechanisms and Therapy 2
-
- Virus-based gene therapy research 1
-
- Synthesis and biological activity 1
- Co-authors
- Martin McMahonJill BechtelDon GanemMichael LagunoffNancy W. AbbeyBrian HerndierIan BeckmanJillian Bradley
- Journals
- Cancer Research (5 papers)Journal of Clinical Oncology (2 papers)American Journal of Respiratory Cell and Molecular Biology (2 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Eleni Venetsanakos
18 papers receiving 692 citations
Peers
Comparison fields: 5 of 71
- Oncology 334
- Immunology and Allergy 54
- Immunology 147
- Cancer Research 72
- Molecular Biology 321
Countries citing papers authored by Eleni Venetsanakos
This map shows the geographic impact of Eleni Venetsanakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Venetsanakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Venetsanakos more than expected).
Fields of papers citing papers by Eleni Venetsanakos
This network shows the impact of papers produced by Eleni Venetsanakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Venetsanakos. The network helps show where Eleni Venetsanakos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eleni Venetsanakos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2018 | 4 | |
| 6 | 2018 | 9 | |
| 7 | 2017 | 22 | |
| 8 | 2017 | 2 | |
| 9 | 2017 | 84 | |
| 10 | 2016 | 3 | |
| 11 | 2014 | 61 | |
| 12 | CHIR-265, a novel inhibitor that targets B-Raf and VEGFR, shows efficacy in a broad range of preclinical models | 2006 | 10 |
| 13 | 2002 | 96 | |
| 14 | 2002 | 164 | |
| 15 | 2001 | 108 | |
| 16 | 1999 | 27 | |
| 17 | Cytokine Gene Therapy of Mesothelioma | 1999 | 1 |
| 18 | 1998 | 38 | |
| 19 | 1997 | 73 |
About Eleni Venetsanakos
Eleni Venetsanakos is a scholar working on Biological Psychiatry, Biotechnology and Oncology, having authored 19 papers that have together received 708 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Fibroblast Growth Factor Research (4 papers), Cancer Research and Treatments (3 papers), Cancer Mechanisms and Therapy (2 papers), Epigenetics and DNA Methylation (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Virus-based gene therapy research (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Oncology (334 citations), Immunology and Allergy (54 citations) and Immunology (147 citations). Eleni Venetsanakos has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Martin McMahon, Jill Bechtel, Don Ganem, Michael Lagunoff, Nancy W. Abbey, Brian Herndier, Ian Beckman, Jillian Bradley, Thea D. Tlsty and Christie Fanton. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, American Journal of Respiratory Cell and Molecular Biology, Molecular Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.